Molecular docking between human TMPRSS2 and the serine protease Kunitz-type inhibitor rBmTI-A
L. d. M. Bomediano-Camillo, S. D. Sasaki
This study investigates the molecular docking of rBmTI-A with TMPRSS2, showing it binds effectively at the SARS-CoV-2 cleavage site with high affinity.
bioRxiv · Mar 13, 2022 · PreprintBiochemistry